Keywords
somatic pathology
chronic obstructive pulmonary disease
prognostic risk model
How to Cite
Abstract
The predictors of periodontal lesions in patients with chronic obstructive pulmonary disease in combination with coronary heart disease were presented in the article. It is proved that the six factors that are included in the mathematical prognostic model of individual risk have the greatest significance. High evidentiary significance of proposed risk model makes possible to develop personalized preventive measures to prevent the periodontal pathology.
References
Бойченко О. М. Структура та захворюваність хвороб пародонта у пацієнтів із ішемічною хворобою серця / О. М. Бойченко, Н. В. Гасюк, О. В. Палій // Свiт медицини та бiологiї. – 2013. – № 9 (1). – С. 21–22.
Association of relationship between periodontal disease and cardiovascular disease / N. Johar, S. V. Dhodapkar, R. Kumar [et al.] // Mymensingh. Med. J. – 2017. – № 26 (2). – P. 439–447.
Ghali R. F. The potential link between periodontitis and systemic diseases – an overview / R. F. Ghali // Journal of Advanced Medical Research. – 2011. – Vol. 1. – P. 24–35.
Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for diagnosis, management, and prevention of chronic obstructive pulmonary disease. – Update 2016. – Retrieved from :
www.goldcopd.com.
Rachelefsky G. S. Impact of inhaled corticosteroid-induced oropharyngeal adverse events: results from meta-analysis / G. S. Rachelefsky, Y. Liao, R. Faruqi // Ann. Allergy Asthma Immunol. – 2007. – № 98. – P. 225–238.
Predischarge screening for chronic obstructive pulmonary disease in patients with acute coronary syndrome and smoking history / G. Campo, R. Pavasini, C. Barbetta [et al.] // Int. J. of Cardiol. – 2016. – № 222. – P. 806–812.
Толох О. С. Хронічне обструктивне захворювання легень: нові вирішення старих проблем / О. С. Толох // Український пуль-монологічний журнал. – 2017. – № 3. – С. 51–56.
Chronic obstructive pulmonary disease and ischemic heart disease comorbidity: overview of mechanisms and clinical management / G. Campo, R. Pavasini, M. Malagù [et al.] // Cardiovasc. Drugs Ther. – 2015. – Vol. 29, № 2. – Р. 147–157. – DOI: 10.1007/s10557-014-6569.